2020年3月26日
对过敏和哮喘患者继续使用皮质类固醇的指导。
阿灵顿高地，生病了。（3月26日，2020年3月） -为了回应美国大学的众多询问Allergies are inappropriate or exaggerated reactions of the immune system to substances that, in the majority of people, cause no symptoms. Symptoms of the allergic diseases may be caused by exposure of the skin to a chemical, of the respiratory system to particles of dust or pollen (or other substances), or of the stomach and intestines to a particular food." rel="tooltip">过敏那Asthma is a chronic, inflammatory lung disease characterized by recurrent breathing problems. People with asthma have acute episodes where the air passages in their lungs get narrower, and breathing becomes more difficult. Sometimes episodes of asthma are triggered by allergens, although infection, exercise, cold air and other factors are also important triggers." rel="tooltip">哮喘＆免疫学（ACAAI）正在为在Covid-19大流行期间对过敏和哮喘患者继续使用皮质类固醇的指导。
随着春季过敏季节的赛，过敏和哮喘患者可能涉及在大流行期间继续建议他们的正常使用吸入和鼻内皮质类固醇。然而，这些患者对这些患者保持症状更重要。
ACAAI提供了以下声明：
随着Covid-19大流行恰逢春季过敏季节，您可能会担心使用您的鼻内皮质类固化剂用于鼻过敏和吸入的皮质类固醇为您的哮喘。没有任何数据，继续这些过敏和哮喘药物对增加Covid-19感染的风险或者如果你得到感染的风险，导致更糟糕的结果。重要的是控制你的过敏和哮喘症状，因为它们可能导致Covid-19的误诊，因为症状有一些重叠。
如果您对过敏和哮喘药物有疑问，请联系您的过敏症或哮喘专家。
关于Acaai.
ACAAI是一个专业医疗组织，超过6000人的过敏症 - 免疫学家和盟军卫生专业人士，生病了，总部位于Arlington Heights，Ill。学院促进了一系列合作和共同性的文化，其成员共同努力和其他人致力于患者的共同目标关怀，教育，宣传和研究。Acaai过敏师是培训过敏和哮喘的董事会认证的医生，施用过敏和哮喘Immunotherapy ("allergy shots") is a form of preventive and anti-inflammatory treatment of allergy to substances such as pollens, house dust mites, fungi, and stinging insect venom. Immunotherapy involves giving gradually increasing doses of the substance, or allergen, to which the person is allergic. The incremental increases of the allergen cause the immune system to become less sensitive to the substance, perhaps by causing production of a particular "blocking" antibody, which reduces the symptoms of allergy when the substance is encountered in the future." rel="tooltip">免疫疗法，并为患者提供最佳的治疗结果。有关更多信息并找到救济，访问AllergyAndasthMarelief.org.。加入我们Facebook那Pinterest.和推特。
过敏治疗那哮喘治疗那新冠肺炎
